InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
58,046.39
(
0.27%
)
Post# of 8779
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

gz69

Send PM Follow Ignore
Followers 11
Posts 819
Boards Moderated 0
Alias Born 10/12/2012

gz69

Re: Larry post# 7134

Thursday, 05/09/2013 8:40:40 AM

Thursday, May 09, 2013 8:40:40 AM

Post# of 8779
ESSI is not marketing Tropine 3. Homatropine is a generic drug that doctors can purchase.

What ESSI is doing is to see FDA approval and also the patent for the novel usage. If they succeed, then they have exclusive right to the patent and only ESSI can sell it as Tropine 3.

You need the 2nd Opinion report.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up